General
Preferred name
nepicastat
Synonyms
SYN117 ()
RS-25560-197 ()
RS-25560-197 hydrochloride ()
NEPICASTAT HYDROCHLORIDE ()
SYN-117 hydrochloride ()
Nepicastat (SYN-117) HCl ()
Nepicastat HCl ()
Nepicastat oral ()
Nepicastat (hydrochloride) ()
Pharmaprojects No. 4698 ()
SYN-117 ()
Nepicastat (hydrochloride) ()
P&D ID
PD047599
CAS
170151-24-3
Tags
available
drug candidate
Drug indication
Post-traumatic stress disorder
Drug Status
investigational
Max Phase
Phase 2
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cytochrome P450 inhibitor; inhibits 20-HETE synthesis (Tocris Bioactive Compound Library)
Compound Sets
18
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugMAP
Guide to Pharmacology
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
37
Properties
(calculated by RDKit )
Molecular Weight
295.1
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
3.01
TPSA
46.74
Fraction CSP3
0.36
Chiral centers
1.0
Largest ring
6.0
QED
0.84
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Dopamine ¦Â-hydroxylase
Dopamine ??-hydroxylase
Dopamine ??hydroxylase
DBH
Dopamine β-hydroxylase
hydroxylase
Pathway
Metabolic Enzyme/Protease
Metabolism
Primary Target
Hydroxylases
MOA
Inhibitor
Dopamine-β-hydroxylase inhibitor
dopamine beta hydroxylase inhibitor
Dopamine-β-hydroxylase inhibitor
Member status
virtual
Source data